Tag: News

11 May 2017

TCD JOINS EOH AS THE GROUP GROWS WITH STRATEGIC CHANGES TAKING EFFECT IN MAY 2017

We are delighted to share the following significant changes and positive developments which took place recently within the TCD Group.

New Ownership

EOH, a JSE-listed South African based Knowledge Management group, have been in negotiation with the TCD Group since the last quarter of 2015, sharing the strategic objective to expand in the field of healthcare. EOH consists of a diverse portfolio of specialised industries in 21 countries across four continents.

The groups came to agreement in October 2016 and the transaction was completed in February 2017. EOH Holdings is now the 100% shareholder of the TCD Group of companies. We are excited by this positive development which opens many new horizons through the global profile of our new proudly South African owners.

The EOH philosophy involves sustaining successful acquisitions by building upon the inherent culture. The TCD Group will remain easily recognisable, building on our rich legacy, striving as always for continuous improvement.

Expansion of the TCD Group

The rapid evolution of the TCD Group expanded the original Triclinium into a full-service CRO (Contract Research Organisation), with a growing range of services and geographical footprint. Triclinium’s sister companies, within the TCD Group now consists of:

  • TCD Outcomes Research: The TCD Group developed a Health Economics and Outcomes Research (HEOR) organisation, through an acquisition of HeXor (a late phase development and pharmacoeconomics company), combined with the Late Phase Clinical Development expertise of TCD.
  • TCD e-Clinical Solutions: The TCD Group created an e-Clinical Solutions division which includes Software as a Service solution. TCD e-Clinical Solutions is focused around improving the outcome of clinical trials from a quality and efficiency perspective. Services include Electronic Data Capture (EDC), Electronic Medical Records (EMR), Electronic Patient Reported Outcomes (ePRO), Electronic Clinical Outcome Assessments (eCOA) and Mobile Health (mHealth), etc.
  • TCD Global Data Services: The TCD Group established and consolidated its Data Management and Biostatistics division under the TCD GDS brand, which is spearheaded out of South Africa and Bangalore, India.
  • TCD-MENA: The TCD Group established a full-service CRO based in Cairo, Egypt through a Joint Venture to focus on the Middle East and North Africa region.
  • PharmaLTX: The TCD Group established a software development company which specialises in software solutions in the wider health care sector such as partnering with Ministries of Health, Regulatory agencies, Institutional Review Boards, Universities, Clinical Research Centres, etc.

 

New TCD Group Chairman

The mandate to meld the member companies into a synergistic group has been entrusted to Dr Tienie Stander, founder of HeXor Pty Ltd., current Managing Director of TCD Outcomes Research, and now also the inaugural Chairman of the TCD Group.

Change in Managing Director of Triclinium Clinical Development

To those who know the company well, the most visible change is that after 17 years at the helm, founder Victor Strugo will relinquish the position of Managing Director to Abraham van Wyk, effective 1st May, 2017. Abraham has been increasingly involved in TCD executive functions since 2014 and his promotion is fully endorsed by TCD’s Board of Directors.

Victor will nevertheless remain active and visible in the new role of TCD Group Strategic Adviser, facilitating a smooth management transition, supporting key projects and developing new horizons for the company that he created in February 2000.

Our electronic media will be updated accordingly over time. We look forward to maintaining and strengthening our association with your organisation through this transition and to offer an ever-improving and broadening range of services in the years ahead.

For queries or more information, contact us at corporate.communications@tcd-global.com

03 Apr 2017

TCD OUTCOMES RESEARCH PROUD TO ANNOUNCE OUR PARTNERSHIP WITH MAKE A DIFFERENCE LEADERSHIP FOUNDATION (MAD LEADERSHIP FOUNDATION)!

As part of our new “Bearing Fruits” CSI initiative, we have chosen to partner with MAD Leadership Foundation to help bring about change in the lives of young South Africans.

MAD Leadership Foundation, founded by Francois Pienaar, focuses on leadership development through education. The approach is to identify deserving scholars with leadership potential, who do not have the necessary financial resources, and offer them comprehensive, long-term and personal support in the areas of education, mentorship, leadership and life-skills development, ensuring they have the necessary tools and opportunities to reach their full potential as future leaders of South Africa.

This partnership includes a monetary donation to pledge our commitment to this cause. Along with this pledge, we will be collecting and donating items needed by the scholars throughout the year. We will also be taking part in the mentorship programme to help develop the leaders of tomorrow.

We are looking forward to this partnership and excited about the journey that lies ahead. Together, let our work and actions benefit humanity!

TCD Outcomes Research is a fully fledged, full service, health economics and outcomes research (HEOR) company serving healthcare companies globally and forms part of the TCD Group. We specialise in late phase health outcomes research by studying the real world value of healthcare solutions and its economic and financial impact. Partner with us to receive a skill set on a continuum of your needs, be it market access, medical, clinical, regulatory, sales or marketing. Convert scientific evidence related to efficacy, safety and quality into a market approach that focuses on real world evidence (RWE) to communicate the value of your product to your stakeholders.

30 May 2016

Interview: Victor Strugo – Managing Director, Triclinium Clinical Development, South Africa

The MD of Triclinium Clinical Development discusses how South Africa’s established First and Third World research opportunities and long-established GCP culture have made it a uniquely attractive country for clinical trials; how Triclinium has grown during a challenging decade, emerging as the largest independent home-bred CRO, winning significant preferred provider agreements and competing successfully against resource-rich international companies; and how the Triclinium brand is poised to take root in new territories.

Read the full article here : http://tcd-global.kbqa.co.za/wp-content/uploads/Pharma-Boardroom-Interview-Victor-Strugy-Jan-2016.pdf